Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Suzuken: Sales Up 4.8% to \1,455 Bil.
June 4, 2007
- Four Major Wholesalers' Sales Up 10.2%, Operating Profits Up 32.8%
June 4, 2007
- Further Revision of Prescription Form Discussed at Chuikyo
May 28, 2007
- Korosho Proposes Increasing Generics' Share to 30% by FY2012
May 28, 2007
- JSMI General Assembly
May 28, 2007
- GENERICS NEWS IN BRIEF
May 28, 2007
- Baxter Focuses on BioScience, Med. Delivery, Renal Therapies: Mr Lema
May 28, 2007
- R&D NEWS IN BRIEF
May 28, 2007
- Top 4 Companies Show Strong Global Sales
May 28, 2007
- Relation between Tamiflu and Sleep to Be Investigated in Clinical Study
May 28, 2007
- Daiichi Sankyo: Growing Sales of Olmesartan Offset Declining Sales of Pravastatin
May 28, 2007
- MOF Questions Insurance Coverage of OTC-Like Drugs
May 28, 2007
- Astellas: Sales Up 4.7% to \920,624 Mil. with 48.9% Overseas
May 28, 2007
- REGULATORY NEWS IN BRIEF
May 28, 2007
- Eisai: Record-High Sales with Increases in Profits 7 Years in a Row
May 28, 2007
- MEDICAL DEVICE NEWS IN BRIEF
May 28, 2007
- Taisho: Worst Performance Since Establishment
May 28, 2007
- New JAS GL Calls For Diagnosis, Management of Dyslipidemia Based on LDL-C
May 28, 2007
- Shionogi: Sales Up 1.7% due to Royalty Income from Crestor
May 28, 2007
- SURVEY／Increased Number of Hospitals Discontinue Dialysis Therapy at Night
May 28, 2007
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…